Merck completes tender offer to acquire Imago BioSciences
Merck intends to complete today the acquisition of Imago through a merger of Merck’s wholly owned subsidiary with and into Imago
Merck intends to complete today the acquisition of Imago through a merger of Merck’s wholly owned subsidiary with and into Imago
As a result, Imago will become a subsidiary of Merck.
Acquisition expands Merck’s growing hematology portfolio
Subscribe To Our Newsletter & Stay Updated